Diabetes. Diabetes mellitus due to underlying condition
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes Having diabetes for at least 6 months Patients treated with oral medication Glycosylated hemoglobin below 10 and above 8 Previous treatment of the patient with 2 grams of metformin and lack of adequate treatment response
Exclusion criteria
Exclusion criteria: Patients consuming minerals, vitamins or antioxidants or medicinal plants Pregnant or lactating women A patient with heart failure Having a chronic disease such as rheumatology diseases Thyroid problems, whether hypothyroid or hyperthyroid Patients receiving NPH insulin (aspartate, lispro and glargine) and regular Patients with kidney failure, chronic kidney disease (GFR > 30 ml/min), liver failure and patients undergoing treatment for gastrointestinal diseases
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting Blood Sugar. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: In serum samples of patients using the Bionic company kit.;Glycosylated hemoglobin. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: In serum samples of patients using the Bionic company kit.;Fasting blood sugar 2 hours after eating. Timepoint: Before the intervention and 3 months after the intervention. Method of measurement: In serum samples of patients using the Bionic company kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Birjand University of Medical Sciences